Get the Stockscreener App
52.00
5.07%
2.51
Soleno Therapeutics Inc stock is traded at $52.00, with a volume of 1.45M.
It is up +5.07% in the last 24 hours and up +8.95% over the past month.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
See More
Previous Close:
$49.49
Open:
$49.8
24h Volume:
1.45M
Relative Volume:
0.73
Market Cap:
$2.79B
Revenue:
-
Net Income/Loss:
$-38.99M
P/E Ratio:
-17.35
EPS:
-2.9966
Net Cash Flow:
$-24.94M
1W Performance:
+1.23%
1M Performance:
+8.95%
6M Performance:
-35.16%
1Y Performance:
+12.36%
1-Day Range:
$49.10
$52.79
1-Week Range:
$48.60
$55.47
52-Week Range:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Name
Soleno Therapeutics Inc
Sector
Industry
Phone
650-213-8444
Address
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Compare SLNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
52.00 | 2.66B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Initiated | Wolfe Research | Outperform |
| Oct-07-25 | Initiated | Goldman | Buy |
| Aug-20-25 | Initiated | Wells Fargo | Overweight |
| Jun-23-25 | Initiated | TD Cowen | Buy |
| Mar-05-25 | Resumed | Stifel | Buy |
| Dec-02-24 | Reiterated | Robert W. Baird | Outperform |
| Dec-02-24 | Reiterated | Stifel | Buy |
| Sep-03-24 | Initiated | H.C. Wainwright | Buy |
| May-10-24 | Initiated | Robert W. Baird | Outperform |
| Feb-05-24 | Initiated | Piper Sandler | Overweight |
| Jan-23-24 | Initiated | Stifel | Buy |
| Nov-21-23 | Resumed | Guggenheim | Buy |
| Sep-29-20 | Initiated | Guggenheim | Buy |
| Jan-10-20 | Initiated | Craig Hallum | Buy |
| Dec-23-19 | Initiated | Oppenheimer | Outperform |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
View All
Soleno Therapeutics Inc Stock (SLNO) Latest News
Soleno Therapeutics, Inc. $SLNO Shares Sold by Holocene Advisors LP - MarketBeat
Soleno Therapeutics Stock Poised for Growth as Wolfe Research Issues Positive Rating - StocksToTrade
Soleno Therapeutics Rises as Wolfe Research Gives Positive Outlook - timothysykes.com
Adage Capital Partners GP L.L.C. Decreases Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Valuation Update: Will Soleno Therapeutics Inc. stock recover faster than peersJuly 2025 Pullbacks & AI Powered Market Entry Ideas - moha.gov.vn
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns - MSN
Technical Reactions to SLNO Trends in Macro Strategies - news.stocktradersdaily.com
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap UpStill a Buy? - MarketBeat
Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise - Benzinga
Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026? - Insider Monkey
Gainers Report: What insider trading reveals about Soleno Therapeutics Inc stockOil Prices & High Return Trade Guides - moha.gov.vn
Diadema Partners LP Has $23.81 Million Stock Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics, Inc. $SLNO Stake Reduced by Vivo Capital LLC - MarketBeat
Marshall Wace LLP Purchases 164,580 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Aug Movers: How buybacks impact Soleno Therapeutics Inc stock valueJuly 2025 Big Picture & Real-Time Buy Signal Notifications - moha.gov.vn
Soleno Therapeutics (NASDAQ:SLNO) Nasdaq Index Clinical Pipeline Growth - Kalkine Media
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Russell Investments Group Ltd. Acquires 82,932 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Rhumbline Advisers Acquires 22,607 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - The Malaysian Reserve
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu - GuruFocus
Soleno Therapeutics board member William Harris passes away By Investing.com - Investing.com Canada
Will Soleno Therapeutics Inc. stock deliver shareholder valueJuly 2025 Short Interest & Verified High Yield Trade Plans - Newser
Why Soleno Therapeutics Inc. (6XC) stock remains stableEarnings Summary Report & High Accuracy Buy Signal Tips - Newser
Is Soleno Therapeutics Inc. stock in correction or buying zoneEarnings Growth Summary & Technical Pattern Based Buy Signals - Newser
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? - Nasdaq
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact ... - Enidnews.com
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire
Soleno Therapeutics board member William Harris passes away - Investing.com
Soleno Therapeutics Announces the Passing of Board Member William G. Harris - The Manila Times
Why Soleno Therapeutics Inc. (6XC) stock is a strong analyst pickMarket Weekly Review & Step-by-Step Trade Execution Guides - Newser
How buybacks impact Soleno Therapeutics Inc. stock valueJuly 2025 Closing Moves & Weekly Chart Analysis and Guides - Newser
How Does Wolfe Research’s Support Shape Soleno Therapeutics’ (SLNO) Credibility Amid Heightened Scrutiny? - simplywall.st
Johnson Fistel Begins Investigation on Behalf of Soleno - GlobeNewswire
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirt - The National Law Review
Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors? - Yahoo Finance
Trading the Move, Not the Narrative: (SLNO) Edition - news.stocktradersdaily.com
Could Soleno Therapeutics Have Room to Run After FDA Designation Sparks 11.8% Rally? - Yahoo Finance
ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages Soleno - The National Law Review
Handelsbanken Fonder AB Acquires Shares of 10,400 Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics, Inc. $SLNO Shares Sold by F m Investments LLC - MarketBeat
Franklin Resources Inc. Buys New Shares in Soleno Therapeutics, Inc. $SLNO - MarketBeat
12 Best Upside Stocks to Buy Now - Insider Monkey
Analyst Dismisses ViCAT XR Safety Fears, Expects Strong Growth Despite Recent Stock Weakness - Finviz
Market Recap: Will Soleno Therapeutics Inc. stock recover faster than peers2025 Top Gainers & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved - MSN
Will Soleno Therapeutics Inc. stock see insider buying2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn
Atika Capital Management LLC Purchases 19,250 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) Shares Up 8.9%What's Next? - MarketBeat
Soleno Therapeutics Inc Stock (SLNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):